The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover

Nucleic Acids Research

Volumn 41, Issue 8, 2013, Pages 4433-4446

  Coffey, Kelly ^a   Rogerson, Lynsey ^a   Ryan Munden, Claudia ^a   Alkharaif, Dhuha ^a   Stockley, Jacqueline ^a   Heer, Rakesh ^a   Sahadevan, Kanagasabai ^a   O'Neill, Daniel ^a   Jones, Dominic ^a   Darby, Steven ^a   Staller, Peter ^b   Mantilla, Alejandra ^a   Gaughan, Luke ^a   Robson, Craig N ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; LYSINE DEMETHYLASE; PROTEIN KDM4B; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GRADING; CONTROLLED STUDY; DEMETHYLATION; ENZYME ANALYSIS; HORMONE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANDROGENS; ANIMALS; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HISTONES; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MALE; PROSTATIC NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 84877313741     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt106     Document Type: Article

References (45)

1. Vakoc, C.R., Sachdeva, M.M., Wang, H. and Blobel, G.A. (2006) Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell Biol., 26, 9185-9195.
2. Vakoc, C.R., Mandat, S.A., Olenchock, B.A. and Blobel, G.A. (2005) Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol. Cell, 19, 381-391.
3. Vicent, G.P., Nacht, A.S., Font-Mateu, J., Castellano, G., Gaveglia, L., Ballare, C. and Beato, M. (2011) Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes Dev., 25, 845-862.
4. Yang, X.D., Huang, B., Li, M., Lamb, A., Kelleher, N.L. and Chen, L.F. (2009) Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J., 28, 1055-1066.
5. Chuikov, S., Kurash, J.K., Wilson, J.R., Xiao, B., Justin, N., Ivanov, G.S., McKinney, K., Tempst, P., Prives, C., Gamblin, S.J. et al. (2004) Regulation of p53 activity through lysine methylation. Nature, 432, 353-360.
6. Fu, M., Wang, C., Reutens, A.T., Wang, J., Angeletti, R.H., Siconolfi-Baez, L., Ogryzko, V., Avantaggiati, M.L. and Pestell, R.G. (2000) p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J. Biol. Chem., 275, 20853-20860.
7. Gaughan, L., Logan, I.R., Neal, D.E. and Robson, C.N. (2005) Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res., 33, 13-26.
8. Poukka, H., Karvonen, U., Janne, O.A. and Palvimo, J.J. (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc. Natl Acad. Sci. USA, 97, 14145-14150.
9. Gaughan, L., Stockley, J., Wang, N., McCracken, S.R., Treumann, A., Armstrong, K., Shaheen, F., Watt, K., McEwan, I.J., Wang, C. et al. (2011) Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res., 39, 1266-1279.
10. Ko, S., Ahn, J., Song, C.S., Kim, S., Knapczyk-Stwora, K. and Chatterjee, B. (2011) Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol. Endocrinol., 25, 433-444.
11. Shin, S. and Janknecht, R. (2007) Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun., 359, 742-746.
12. Metzger, E., Wissmann, M., Yin, N., Muller, J.M., Schneider, R., Peters, A.H., Gunther, T., Buettner, R. and Schule, R. (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature, 437, 436-439.
13. Katoh, M. (2004) Identification and characterization of JMJD2 family genes in silico. Int. J. Oncol., 24, 1623-1628.
14. Fodor, B.D., Kubicek, S., Yonezawa, M., O'Sullivan, R.J., Sengupta, R., Perez-Burgos, L., Opravil, S., Mechtler, K., Schotta, G. and Jenuwein, T. (2006) Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev., 20, 1557-1562.
15. Shi, L., Sun, L., Li, Q., Liang, J., Yu, W., Yi, X., Yang, X., Li, Y., Han, X., Zhang, Y. et al. (2011) Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl Acad. Sci. USA, 108, 7541-7546.
16. Kawazu, M., Saso, K., Tong, K.I., McQuire, T., Goto, K., Son, D.O., Wakeham, A., Miyagishi, M., Mak, T.W. and Okada, H. (2011) Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One, 6, e17830.
17. Brady, M.E., Ozanne, D.M., Gaughan, L., Waite, I., Cook, S., Neal, D.E. and Robson, C.N. (1999) Tip60 is a nuclear hormone receptor coactivator. J. Biol. Chem., 274, 17599-17604.
18. Beyer, S., Kristensen, M.M., Jensen, K.S., Johansen, J.V. and Staller, P. (2008) The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem., 283, 36542-36552.
19. Camus, S., Menendez, S., Cheok, C.F., Stevenson, L.F., Lain, S. and Lane, D.P. (2007) Ubiquitin-independent degradation of p53 mediated by high-risk human papillomavirus protein E6. Oncogene, 26, 4059-4070.
20. Sramkoski, R.M., Pretlow, T.G. II, Giaconia, J.M., Pretlow, T.P., Schwartz, S., Sy, M.S., Marengo, S.R., Rhim, J.S., Zhang, D. and Jacobberger, J.W. (1999) A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell. Dev. Biol. Anim., 35, 403-409.
21. Halkidou, K., Gnanapragasam, V.J., Mehta, P.B., Logan, I.R., Brady, M.E., Cook, S., Leung, H.Y., Neal, D.E. and Robson, C.N. (2003) Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene, 22, 2466-2477.
22. Rigas, A.C., Robson, C.N. and Curtin, N.J. (2007) Therapeutic potential of CDK inhibitor NU2058 in androgen-independent prostate cancer. Oncogene, 26, 7611-7619.
23. Armstrong, K., Robson, C.N. and Leung, H.Y. (2006) NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. Prostate, 66, 1223-1234.
24. Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J. and Zhang, Y. (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell, 125, 483-495.
25. Wissmann, M., Yin, N., Muller, J.M., Greschik, H., Fodor, B.D., Jenuwein, T., Vogler, C., Schneider, R., Gunther, T., Buettner, R. et al. (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell Biol., 9, 347-353.
26. Welsbie, D.S., Xu, J., Chen, Y., Borsu, L., Scher, H.I., Rosen, N. and Sawyers, C.L. (2009) Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. Cancer Res., 69, 958-966.
27. Lin, H.K., Wang, L., Hu, Y.C., Altuwaijri, S. and Chang, C. (2002) Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J., 21, 4037-4048.
28. Shukla, A., Chaurasia, P. and Bhaumik, S.R. (2009) Histone methylation and ubiquitination with their cross-talk and roles in gene expression and stability. Cell Mol. Life Sci., 66, 1419-1433.
29. Ishimura, A., Terashima, M., Kimura, H., Akagi, K., Suzuki, Y., Sugano, S. and Suzuki, T. (2009) Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene. Biochem. Biophys. Res. Commun., 389, 366-371.
30. Wright, M.E., Tsai, M.J. and Aebersold, R. (2003) Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells. Mol. Endocrinol., 17, 1726-1737.
31. Cloos, P.A., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K.H. and Helin, K. (2006) The putative oncogene GASC1 demethylates tri-and dimethylated lysine 9 on histone H3. Nature, 442, 307-311.
32. Fu, L., Chen, L., Yang, J., Ye, T., Chen, Y. and Fang, J. (2012) HIF-1alpha-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Carcinogenesis, 33, 1664-1673.
33. Yang, J., Jubb, A.M., Pike, L., Buffa, F.M., Turley, H., Baban, D., Leek, R., Gatter, K.C., Ragoussis, J. and Harris, A.L. (2010) The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res., 70, 6456-6466.
34. Nicolas, E., Roumillac, C. and Trouche, D. (2003) Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter. Mol. Cell. Biol., 23, 1614-1622.
35. Adamsen, B.L., Kravik, K.L., Clausen, O.P. and De Angelis, P.M. (2007) Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int. J. Oncol., 31, 1491-1500.
36. Pollard, P.J., Loenarz, C., Mole, D.R., McDonough, M.A., Gleadle, J.M., Schofield, C.J. and Ratcliffe, P.J. (2008) Regulation of Jumonji-domain- containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem. J., 416, 387-394.
37. Massie, C.E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N. et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J., 30, 2719-2733.
38. Rivera-Gonzalez, G.C., Droop, A.P., Rippon, H.J., Tiemann, K., Pellacani, D., Georgopoulos, L.J. and Maitland, N.J. (2012) Retinoic acid and androgen receptors combine to achieve tissue specific control of human prostatic transglutaminase expression: a novel regulatory network with broader significance. Nucleic Acids Res., 40, 4825-4840.
39. Guseva, N.V., Rokhlin, O.W., Bair, T.B., Glover, R.B. and Cohen, M.B. (2012) Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor. Oncotarget, 3, 183-194.
40. Wyce, A., Bai, Y., Nagpal, S. and Thompson, C.C. (2010) Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function. Mol. Endocrinol., 24, 1665-1674.
41. Chen, H., Libertini, S.J., George, M., Dandekar, S., Tepper, C.G., Al-Bataina, B., Kung, H.J., Ghosh, P.M. and Mudryj, M. (2010) Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines. Endocr. Relat. Cancer, 17, 857-873.
42. Urbanucci, A., Sahu, B., Seppala, J., Larjo, A., Latonen, L.M., Waltering, K.K., Tammela, T.L., Vessella, R.L., Lahdesmaki, H., Janne, O.A. et al. (2012) Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer. Oncogene, 31, 2153-2163.
43. Milosevic, M., Chung, P., Parker, C., Bristow, R., Toi, A., Panzarella, T., Warde, P., Catton, C., Menard, C., Bayley, A. et al. (2007) Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response. Cancer Res., 67, 6022-6025.
44. Horii, K., Suzuki, Y., Kondo, Y., Akimoto, M., Nishimura, T., Yamabe, Y., Sakaue, M., Sano, T., Kitagawa, T., Himeno, S. et al. (2007) Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells. Mol. Cancer Res., 5, 383-391.
45. Park, S.Y., Kim, Y.J., Gao, A.C., Mohler, J.L., Onate, S.A., Hidalgo, A.A., Ip, C., Park, E.M., Yoon, S.Y. and Park, Y.M. (2006) Hypoxia increases androgen receptor activity in prostate cancer cells. Cancer Res., 66, 5121-5129.